{"id": "1345969513582399489", "creation": 1609739113.0, "user_id": "2936776459", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Cadila #Healthcare\u00a0#share #price rose over 3% after the #company #received #Drug #Controller #General of\u00a0#India's\u00a0(#DCGI) #approval to #initiate #Phase III #clinical #trials of its #COVID19 #vaccine, ZyCoV-D.\n\nhttps://t.co/qfyRSRG6AE", "first_save": 1634559108.199414, "hashtags": ["#CADILA", "#HEALTHCARE", "#SHARE", "#PRICE", "#COMPANY", "#RECEIVED", "#DRUG", "#CONTROLLER", "#GENERAL", "#INDIA", "#DCGI", "#APPROVAL", "#INITIATE", "#PHASE", "#CLINICAL", "#TRIALS", "#COVID19", "#VACCINE"]}